Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
914,828
-
Share change
-
+49,305
-
Total reported value
-
$13,173,392
-
Price per share
-
$14.40
-
Number of holders
-
27
-
Value change
-
+$709,637
-
Number of buys
-
13
-
Number of sells
-
7
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q4 2019
As of 31 Dec 2019,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
914,828 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Fondren Management LP, VANGUARD GROUP INC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, PERRITT CAPITAL MANAGEMENT INC, BlackRock Inc., WEDGE CAPITAL MANAGEMENT L L P/NC, Advisor Group, Inc., and Advisory Services Network, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.